SUMO-1 CRISPR Knockout and Activation Products (h)
Descrição
SUMO-1 CRISPR Knockout and Activation Plasmids (h) designed to edit, knockdown or upregulate human SUMO-1 gene expression
![SUMO-1 CRISPR Knockout and Activation Products (h)](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-30134-9/MediaObjects/41467_2022_30134_Fig1_HTML.png)
Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screen
![SUMO-1 CRISPR Knockout and Activation Products (h)](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-022-32920-x/MediaObjects/41467_2022_32920_Fig1_HTML.png)
Crosstalk between SUMOylation and ubiquitylation controls DNA end resection by maintaining MRE11 homeostasis on chromatin
human USE1-specific CRISPR/Cas9 KO Plasmid, HDR Plasmid, Double Nickase Plasmids, CRISPR Activation Plasmids and Lentiviral Activation Particles
![SUMO-1 CRISPR Knockout and Activation Products (h)](https://media.scbt.com/product/use1-crispr-knockout-and-activation-products-h-_32_48_b_324833.jpg)
USE1 CRISPR Plasmids (h)
![SUMO-1 CRISPR Knockout and Activation Products (h)](https://www.science.org/cms/asset/ffa3480f-e07f-46ca-932c-2f7bbdfa971d/aba6290-f1.gif)
A conserved SUMO pathway repairs topoisomerase DNA-protein cross-links by engaging ubiquitin-mediated proteasomal degradation
![SUMO-1 CRISPR Knockout and Activation Products (h)](https://www.frontiersin.org/files/Articles/800810/fphar-13-800810-HTML/image_m/fphar-13-800810-g001.jpg)
Frontiers Natural Products Against Renal Fibrosis via Modulation of SUMOylation
![SUMO-1 CRISPR Knockout and Activation Products (h)](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41556-018-0202-4/MediaObjects/41556_2018_202_Fig1_HTML.png)
CRISPR–Cas9-mediated base-editing screening in mice identifies DND1 amino acids that are critical for primordial germ cell development
![SUMO-1 CRISPR Knockout and Activation Products (h)](https://media.scbt.com/product/sumo-1-crispr-knockout-and-activation-products-h-_31_32_z_313293.jpg)
SUMO-1 CRISPR Knockout and Activation Products (h)
![SUMO-1 CRISPR Knockout and Activation Products (h)](https://horizondiscovery.com/-/media/Images/Horizon/applications/pathways-sumoylation.png?h=165&w=250&hash=CC0EC0616B488F5B8043CD1C33B907B5)
Cell Lines For Studying Sumoylation
![SUMO-1 CRISPR Knockout and Activation Products (h)](https://www.mdpi.com/cancers/cancers-13-04402/article_deploy/html/images/cancers-13-04402-g001.png)
Cancers, Free Full-Text
![SUMO-1 CRISPR Knockout and Activation Products (h)](https://www.frontiersin.org/files/Articles/813428/fmolb-09-813428-HTML/image_m/fmolb-09-813428-g004.jpg)
Frontiers Identification of UBE2I as a Novel Biomarker in ccRCC Based on a Large-Scale CRISPR-Cas9 Screening Database and Immunohistochemistry
![SUMO-1 CRISPR Knockout and Activation Products (h)](https://pub.mdpi-res.com/ijms/ijms-24-06545/article_deploy/html/images/ijms-24-06545-g001.png?1680251786)
IJMS, Free Full-Text
de
por adulto (o preço varia de acordo com o tamanho do grupo)